- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2522-5782
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Case report: Medical cannabis—warfarin drug-drug interaction ; volume:4 ; number:1 ; day:10 ; month:1 ; year:2022 ; pages:1-6 ; date:12.2022
Journal of cannabis research ; 4, Heft 1 (10.1.2022), 1-6, 12.2022
- Urheber
-
Thomas, Tyan F.
Metaxas, Evdokia S.
Nguyen, Thu
Bennett, Whitni
Skiendzielewski, Kathryn V.
Quinn, Diane H.
Scaletta, Alice L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42238-021-00112-x
- URN
-
urn:nbn:de:101:1-2022042500563690696859
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thomas, Tyan F.
- Metaxas, Evdokia S.
- Nguyen, Thu
- Bennett, Whitni
- Skiendzielewski, Kathryn V.
- Quinn, Diane H.
- Scaletta, Alice L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lurasidone drug-drug interaction studies: a comprehensive review
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
Learning self-supervised molecular representations for drug–drug interaction prediction
Evaluation of a drug-drug interaction: fax alert intervention program
On the robustness of generalization of drug–drug interaction models
Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
Lurasidone drug-drug interaction studies: a comprehensive review
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
Learning self-supervised molecular representations for drug–drug interaction prediction
Evaluation of a drug-drug interaction: fax alert intervention program
On the robustness of generalization of drug–drug interaction models
Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
Lurasidone drug-drug interaction studies: a comprehensive review
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
Learning self-supervised molecular representations for drug–drug interaction prediction
Evaluation of a drug-drug interaction: fax alert intervention program
On the robustness of generalization of drug–drug interaction models
Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels
Targeting continuity of care and polypharmacy to reduce drug–drug interaction